Loading company…
Yinsheng Medical develops biological 3D printing technology and regenerative medical devices.
Yinsheng Medical develops regenerative medical devices for tissue repair and cell therapy, including soft and hard tissue membranes and stem cell therapy carriers. Founded in 2022 and based in Hangzhou, China, the company raised pre-Series A funding in December 2025 led by Roton Capital, with Dongfang State-owned Assets, Huayu Win-Win Venture Capital Management, and Linping Economic Development Zone participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in